These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension. Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045 [TBL] [Abstract][Full Text] [Related]
6. Plasma levels of proadrenomedullin N-terminal 20 peptide and adrenomedullin in patients undergoing hemodialysis. Tokura T; Kinoshita H; Fujimoto S; Kitamura K; Eto T Nephron Clin Pract; 2003; 95(2):c67-72. PubMed ID: 14610332 [TBL] [Abstract][Full Text] [Related]
7. Source of plasma adrenomedullin in a patient with pheochromocytoma receiving hemodialysis. Nomura T; Yamasaki M; Satoh F; Nomura Y; Mimata H Int J Urol; 2006 Apr; 13(4):427-30. PubMed ID: 16734863 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure. Ishihara T; Yokota N; Hisanaga S; Fujimoto S; Hirayama N; Kato J; Kitamura K; Eto T Clin Nephrol; 1999 Aug; 52(2):119-23. PubMed ID: 10480223 [TBL] [Abstract][Full Text] [Related]
9. Effects of long and short hemodialysis on endothelial function: a short-term study. McGregor DO; Buttimore AL; Lynn KL; Yandle T; Nicholls MG Kidney Int; 2003 Feb; 63(2):709-15. PubMed ID: 12631138 [TBL] [Abstract][Full Text] [Related]
11. Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. Nishikimi T; Horio T; Kohmoto Y; Yoshihara F; Nagaya N; Inenaga T; Saito M; Teranishi M; Nakamura M; Ohrui M; Kawano Y; Matsuo H; Ishimitsu T; Takishita S; Matsuoka H; Kangawa K J Hypertens; 2001 Apr; 19(4):765-73. PubMed ID: 11330880 [TBL] [Abstract][Full Text] [Related]
12. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Franz M; Woloszczuk W; Hörl WH Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584 [TBL] [Abstract][Full Text] [Related]
13. Characterization of immunoreactive adrenomedullin in human plasma and urine. Sato K; Hirata Y; Imai T; Iwashina M; Marumo F Life Sci; 1995; 57(2):189-94. PubMed ID: 7603298 [TBL] [Abstract][Full Text] [Related]
14. Mature form of adrenomedullin is a useful marker to evaluate blood volume in hemodialysis patients. Kanozawa K; Shimosawa T; Nagasawa R; Matsuda A; Kato H; Matsumura O; Mitarai T; Isoda K; Fujita T Am J Kidney Dis; 2002 Oct; 40(4):794-801. PubMed ID: 12324915 [TBL] [Abstract][Full Text] [Related]
15. Effect of a hemodialysis session on plasma levels of endothelin-1 in hypertensive and normotensive subjects with end-stage renal failure. Surdacki A; Sułowicz W; Wieczorek-Surdacka E; Herman ZS Nephron; 1999 Jan; 81(1):31-6. PubMed ID: 9884416 [TBL] [Abstract][Full Text] [Related]
16. Increased plasma levels of adrenomedullin in patients with hemodialysis. Nitta K; Kawashima A; Oba T; Kikawada E; Narusawa K; Mimuro T; Kabaya T; Nihei H Nephron; 2000 Aug; 85(4):360-2. PubMed ID: 10940752 [No Abstract] [Full Text] [Related]
17. Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Sumimoto T; Nishikimi T; Mukai M; Matsuzaki K; Murakami E; Takishita S; Miyata A; Matsuo H; Kangawa K Hypertension; 1997 Sep; 30(3 Pt 2):741-5. PubMed ID: 9323016 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. Ishimitsu T; Nishikimi T; Saito Y; Kitamura K; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H J Clin Invest; 1994 Nov; 94(5):2158-61. PubMed ID: 7962564 [TBL] [Abstract][Full Text] [Related]